J7507 HCPCS code: Tacrolimus, immediate release, oral, 1 mg
J7507 is the HCPCS Level II code for tacrolimus, immediate release, oral, 1 mg. In 2024 Medicare paid an average of $0.18 per service for J7507 across 74,439,714 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 1200 per day on DME suppliers. Medicare volume fell 14% from 2022 to 2024 (86,276,057 to 74,439,714 services). In 2024, 18,343 suppliers billed Medicare for J7507 (purchases), serving 69,815 beneficiaries; California, New York, Florida accounted for 29% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1995-01-01 |
| Last action effective | 2014-01-01 |
Who bills J7507 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 18,343 |
| Referring clinicians | 16,541 |
| Medicare beneficiaries | 69,815 |
| States with claims | 52 |
| Share of services in top 3 states (California, New York, Florida) | 29% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 19,686 | 76,152 |
| 2023 | 19,274 | 73,126 |
| 2024 | 18,343 | 69,815 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7507, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 86,276,057 | 76,152 | $0.41 | $0.30 |
| 2023 | 80,616,236 | 73,126 | $0.31 | $0.23 |
| 2024 | 74,439,714 | 69,815 | $0.25 | $0.18 |
States with the most J7507 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 9,701,144 | $0.18 |
| New York | 6,356,248 | $0.19 |
| Florida | 5,518,076 | $0.18 |
| Texas | 5,304,044 | $0.18 |
| Pennsylvania | 3,717,484 | $0.18 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 1200 | Published Contractor Policy |
| outpatient hospital claims | 40 | Prescribing Information |
What changed for J7507
- 1995-01-01: J7507 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7507?
J7507 is the HCPCS Level II code for tacrolimus, immediate release, oral, 1 mg. Short descriptor: "Tacrolimus imme rel oral 1mg".
How much does Medicare pay for J7507?
In 2024, the average Medicare payment was $0.18 per service (average allowed $0.25).
Does Medicare cover J7507?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J7507 can be billed per day?
1200 on DME suppliers; 40 on outpatient hospital claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7502 — Cyclosporine, oral, 100 mg
- J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7510 — Prednisolone oral, per 5 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512 — Prednisone, immediate release or delayed release, oral, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7507
- Watch J7507 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7507
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.